Dr Paweł Wiśniewski has over 12 years of experience in development and implementation of biotechnology business strategies, which he has gained by holding top management positions in multiple companies within new technologies, biotech and healthcare sectors. He is also an author and co-author of numerous scientific papers, recognised at the international level.
Dr Wiśniewski is a founder and CEO of Instytut Analiz Genetycznych sp. z o.o. - INAGEN, a Poland-based company providing genetic profiling solutions to professional sports entities and individual athletes. He also holds a position of Vice-President of the Management Board of 4Cell Therapies S.A., a biotechnological company developing cell therapies for treatment of haematological and solid malignancies in Poland.
At the same time, Dr Wiśniewski provides advisory services to the investors and biotechnological companies world-wide and holds a position of Vice-Chairman of the Supervisory Board at Pure Biologics S.A., a publicly listed biotechnological company.
Project Manager with many years of experience in medical companies, with foreign capital or managed by investment funds, with extensive management experience both in terms of investment and other areas related to the development of operating activities. Theoretical knowledge in the field of project management has been supplemented by practical implementation of complex projects of a unique nature. In addition to the investment and project area, cooperation with private equity funds on mergers, acquisitions and consulting projects has resulted in a broad view of investments in the medical services sector.
Active participant in the medical market in Poland since 1991
CEO & Founder (2002) of HammerMed Medical Polska Ltd LLP (one of the leading supplier of medical devices in Poland)
CEO & Founder (2009) of HammerMed II Nieruchomosci Ltd LLP
Expert in introducing minimal invasive devices into the market
Co-author of articles on the treatment of thoraco-abdominal aneurysms
Advisor – investor and entrepreneur with IT background with over 10 years of experience
In 2010 co-founded and managed first online currency exchange business in Poland (internetowykantor.pl and walutomat.pl) that grew up to 100 people and 1B PLN monthly turnover. Successfully exited in 2017
Since 2017 investor and advisor in multiple technology startups
SVP of McKinsey Restructuring in London
Lead improvement projects for main Polish Oncological Centers
Former COO of Allianz Poland, Cersanit (consumer goods) and PKN ORLEN (chemicals)
30 years of C-level experience in business development, turnaround/ restructuring and performance improvement across a variety of industries and continents